Your search history is turned on.
Date: April 15, 2024 Jurisdictions: British Columbia, Ontario
ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024 Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of immuno-oncology, is pleased to announce that the Company's management will be ringing the opening ...
Date: April 10, 2024 Jurisdictions: British Columbia, Ontario
Microsoft Word - ME THERAPEUTICS Material Change Report for News Release announcing grant of stock options on Apri(25197456.1) FORM51102F3 MATERIALCHANGEREPORT Item1. NameandAddressofCompany METherapeuticsHoldingsInc.(theCompany) 177RobsonStreet Vancouver,BCV6B0N3 Item2. DateofMaterialChange April8,2024 Ite...
Date: April 8, 2024 Jurisdictions: British Columbia, Ontario
Microsoft Word - ME Therapeutics - News release announcing grant of stock options (April 2024).docx METHERAPEUTICSHOLDINGSINC.ANNOUNCESGRANTOFSTOCKOPTIONS VANCOUVER,BCApril8,2024METherapeuticsHoldingsInc.(METX:CSE)(FSE:Q9T),apreclinicalstage biotechnology company working on novel cancer fighting drugs in the field ...
Date: March 26, 2024 Jurisdictions: British Columbia, Ontario
Microsoft Word - ME Therapeutics Final News Release announcing participation at Bloom Burton investor conference a(21762154.1). METHERAPEUTICSHOLDINGSINC.ANNOUNCESUPCOMINGPARTICIPATIONINTHE2024 BLOOMBURTON&COHEALTHCARECONFERENCEANDINTERVIEWONCSETV VANCOUVER,BCMarch26,2024METherapeuticsHoldingsInc.(METX:CSE)(FSE:Q9T),a...
Date: March 22, 2024 Jurisdictions: British Columbia, Ontario
Trifecta Gold Ltd. ME THERAPEUTICS HOLDINGS INC. Managements Discussion and Analysis for the Six Months ended February 29, 2024 (including Subsequent Events to March 22, 2024) The following discussion and analysis of the results of operations and financial condition of ME Therapeutics Holdings Inc. (formerly Metx Research Corp.) (METX or the C...
Microsoft Word - ME THERAPEUTICS CFO Certification for February 29_ 2024(21750510.1).doc Form52109FV2 CertificationofInterimFilings VentureIssuerBasicCertificate I,QuinnMartin,ChiefFinancialOfficerofMETherapeuticsHoldingsInc.,certifythefollowing: 1. Review:IhavereviewedtheinterimfinancialreportandinterimMD&A(toge...
Microsoft Word - ME THERAPEUTICS CEO Certification for February 29_ 2024(21750501.1).doc Form52109FV2 CertificationofInterimFilings VentureIssuerBasicCertificate I,SalimDhanji,ChiefExecutiveOfficerofMETherapeuticsHoldingsInc.,certifythefollowing: 1. Review:IhavereviewedtheinterimfinancialreportandinterimMD&A(toge...
FORM 51-901F ME Therapeutics Holdings Inc. (formerly Metx Research Corp.) Condensed Interim Consolidated Financial Statements For the six months ended February 29, 2024 Unaudited Prepared by Management (Expressed in Canadian Dollars) NOTICE OF NO AUDITOR REVIEW OF...
Date: March 6, 2024 Jurisdictions: Alberta, British Columbia
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...
Date: March 6, 2024 Jurisdictions: British Columbia, Ontario
Microsoft Word - ME THERAPEUTICS Material Change Report for News Release announcing closing of private placement(21655093.1).d FORM51102F3 MATERIALCHANGEREPORT Item1. NameandAddressofCompany METherapeuticsHoldingsInc.(theCompany) 177RobsonStreet Vancouver,BCV6B0N3 Item2. DateofMaterialChange March5,2024 Item...